(S)-17-Hydrazono-13-methyl-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthren-3-ol

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 类固醇和类固醇衍生物
• 英文名称: (S)-17-Hydrazono-13-methyl-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthren-3-ol
• 英文别名: (8xi,9xi,14xi,17E)-17-hydrazinylideneestra-1,3,5(10)-trien-3-ol；(13S,17E)-17-hydrazinylidene-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-ol
• 化学式: C₁₈H₂₄N₂O
• mdl: MFCD02647839
• 分子量: 284.401
• InChiKey: GWWXKVVUGDVQGO-VHBPWQNCSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.1
• 重原子数：
  21
• 可旋转键数：
  0
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.61
• 拓扑面积：
  58.6
• 氢给体数：
  2
• 氢受体数：
  3

文献信息

• Biologically active peptide VAPEEHPTLLTEAPLNPK derivatives
  申请人：CMS Peptides Patent Holding Company Limited

  公开号：EP2058328B1

  公开（公告）日：2011-04-13
• POLYCYCLIC PHENOLIC COMPOUNDS AND USE IN TREATING VIRAL INFECTIONS
  申请人：Dugourd Dominique

  公开号：US20070161611A1

  公开（公告）日：2007-07-12

  The present invention provides antiviral polycyclic phenolic compounds (PPCs) for use in treating or preventing viral infections and associated conditions, such as infections by Flaviviridae, Hepadnaviridae, Herpesviridae, Papillomaviridae, Retroviridae, Adenoviridae, or respiratory viruses (such as Adenoviridae, Orthomyxoviridae, Paramyxoviridae and Coronaviridae).
• Biologically Active Peptide Vapeehptllteaplnpk Derivatives
  申请人：WONG Wai Ming

  公开号：US20080125372A1

  公开（公告）日：2008-05-29

  Peptides derived from the peptide CMS-010, which has the formula VAPEEHPTLLTEAPLNPK, are disclosed with their use as pharmaceutical compositions. A method is also disclosed for making a pharmaceutical composition comprising providing a peptide derived from CMS-010 and mixing said peptide with a pharmaceutical acceptable carrier.
• BIOLOGICALLY ACTIVE PEPTIDE VAPEEHPTLLTEAPLNPK DERIVATIVES
  申请人：WONG Wai Ming

  公开号：US20080146510A1

  公开（公告）日：2008-06-19

  Peptides derived from the peptide CMS-010, which has the formula VAPEEHPTLLTEAPLNPK, are disclosed with their use as pharmaceutical compositions. A method is also disclosed for making a pharmaceutical composition comprising providing a peptide derived from CMS-010 and mixing said peptide with a pharmaceutical acceptable carrier.
• COMPOUNDS AND METHODS FOR CYTOPROTECTION
  申请人：Pei Yazhong

  公开号：US20080171034A1

  公开（公告）日：2008-07-17

  Compounds, compositions and methods for treating degenerative diseases and disorders are disclosed, the compounds having the following structure (I): including stereoisomers, prodrugs and pharmaceutically acceptable salts thereof, wherein R 1 and R 2 are as defined herein.